Health Catalyst (HCAT) Misses Q4 EPS by 2c

Health Catalyst (NASDAQ: HCAT) reported Q4 EPS of $0.08, $0.02 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $74.8 million versus the consensus estimate of $73.82 million.

For earnings history and earnings-related data on Health Catalyst (HCAT) click here.

You May Also Be Interested In

• Trump Bought At Least $100,001 In Palantir Shares, Disclosure Shows - Bloomberg
• Allison Transmission to Join S&P MidCap 400; Goodyear Tire & Rubber to Join S&P SmallCap 600
• Oppenheimer turns cautious on major U.S. banks, favors alternative asset managers